The United Kingdom's publicly funded National Health Service (NHS) is entering a period of transition due to a growth in private healthcare providers. In response, the NHS must become more competitive; identifying competitive advantage, best practice and adopting formal management methods. The...

This paper studies the impact of R&D spending on output as well as forecasting the impact of a regionally enhanced R&D tax credit on the 'user cost' (or price) of R&D expenditure and subsequently the demand for R&D. The example we use of a 'disadvantaged' region is Northern Ireland (partly...

We model the determinants of donations made to UK overseas development charities using panel data on charities’ donation income covering a 25 year period. The paper starts by reviewing relevant theory and previous empirical work on donations to UK charities before outlining a framework in...

This paper takes both a practical and critical view of economic analysis in relation to the third sector. It argues that there is no one kind of economic analysis but that a certain form of such thinking, and associated techniques, has become dominant in thinking and practice. That mainstream...

The global financial crisis was triggered by the bursting of the United States housing bubble in 2007 and the reverberations of this are now being felt throughout the world. The crisis was greatly exacerbated by the behaviour of banks, which has inevitably made the position of any country that...

We study three topics on corruption that are of particular relevance to sub-Saharan Africa. Firstly, we address the question of why corruption is such an endemic problem in sub-Saharan Africa. Is it policy driven or "destiny"? We analyse indices of perceived corruption and test several theories...

This paper examines whether or not hospital competition in a market with fixed reimbursement prices can prompt improvements in clinical quality. In January 2006, the British Government introduced a major extension of their market-based reforms to the English National Health Service. From January...

This paper investigates how regulation impinges on the launch strategies of international pharmaceutical corporations for new molecules and generics across the main OECD markets during 1960-2008. Comprehensive IMS data is used to analyze the international diffusion of 845 molecules from 14...

This paper examines whether or not hospital competition in a market with fixed reimbursement prices can prompt improvements in clinical quality. In January 2006, the British Government introduced a major extension of their market-based reforms to the English National Health Service. From January...

Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to...